Page last updated: 2024-10-23

beta-naphthoflavone and Breast Neoplasms

beta-naphthoflavone has been researched along with Breast Neoplasms in 5 studies

beta-Naphthoflavone: A polyaromatic hydrocarbon inducer of P4501A1 and P4501A2 cytochromes. (Proc Soc Exp Biol Med 1994 Dec:207(3):302-308)
beta-naphthoflavone : An extended flavonoid resulting from the formal fusion of a benzene ring with the f side of flavone.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
" The effect of arylhydrocarbon receptor agonist beta-naphthoflavone on the content of 8-hydroxy-2-deoxyguanosine and number of estrogen and progesterone receptors was evaluated in MCF-7 breast cancer cells."7.73Content of 8-hydroxy-2-deoxyguanosine in steroid receptor-positive and receptor-negative breast cancer cells. ( Bershtein, LM; Levina, VV; Poroshina, TE; Tsyrlina, EV, 2005)
" The effect of arylhydrocarbon receptor agonist beta-naphthoflavone on the content of 8-hydroxy-2-deoxyguanosine and number of estrogen and progesterone receptors was evaluated in MCF-7 breast cancer cells."3.73Content of 8-hydroxy-2-deoxyguanosine in steroid receptor-positive and receptor-negative breast cancer cells. ( Bershtein, LM; Levina, VV; Poroshina, TE; Tsyrlina, EV, 2005)
"Thus, some human breast tumors had AHH activity exceeding that in rat liver."1.26Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors. ( Mason, ME; Okey, AB, 1981)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, C1
Xu, CX1
Bu, Y1
Bottum, KM1
Tischkau, SA1
Hanioka, N1
Iwabu, H1
Hanafusa, H1
Nakada, S1
Narimatsu, S1
Bershtein, LM1
Levina, VV1
Poroshina, TE1
Tsyrlina, EV1
Nwankwo, JO1
Mason, ME1
Okey, AB1

Other Studies

5 other studies available for beta-naphthoflavone and Breast Neoplasms

ArticleYear
Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling.
    Carcinogenesis, 2014, Volume: 35, Issue:3

    Topics: Base Sequence; beta-Naphthoflavone; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Primers; Ext

2014
Expression and inducibility of UDP-glucuronosyltransferase 1As in MCF-7 human breast carcinoma cells.
    Basic & clinical pharmacology & toxicology, 2012, Volume: 110, Issue:3

    Topics: beta-Naphthoflavone; Breast Neoplasms; Cell Line, Tumor; Dexamethasone; Enzyme Induction; Female; Ge

2012
Content of 8-hydroxy-2-deoxyguanosine in steroid receptor-positive and receptor-negative breast cancer cells.
    Bulletin of experimental biology and medicine, 2005, Volume: 140, Issue:1

    Topics: 8-Hydroxy-2'-Deoxyguanosine; beta-Naphthoflavone; Breast Neoplasms; Deoxyguanosine; DNA Damage; Estr

2005
Significant transcriptional down-regulation of the human MDR1 gene by beta-naphthoflavone: a proposed hypothesis linking potent CYP gene induction to MDR1 inhibition.
    Medical hypotheses, 2007, Volume: 68, Issue:3

    Topics: 3T3 Cells; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta-Naphthoflavone; Br

2007
Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors.
    Cancer research, 1981, Volume: 41, Issue:7

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzo(a)pyrene; Benzoflavones; Benzopyrenes; beta-Naphthofla

1981